Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Mol Cancer Res. 2011 Feb 22;9(3):271–279. doi: 10.1158/1541-7786.MCR-10-0496

Table 1.

Relationship of clinical variables to functional classification of p53 germline alleles based on the mean transactivation activity. For each allele, transactivation was determined quantitatively (luciferase-based) in 4 different reporter strains. Alleles were classified as Severe Deficiency (SD) or Partial Deficiency (PD) alleles if their mean residual activity was <25% or ≥25% of that of the WT allele (100% activity), respectively. A separate group of 52 alleles were classified as Obligate Severe Deficiency (O-SD) alleles in terms of transactivation, by virtue of nonsense mutations, frameshifts or other mutations that give rise to a truncated protein. The p values are for testing whether the proportion of families exhibiting a given clinical characteristic differed according to the type of allele carried by the family.

SD PD O-SD SD
vs PD
(p value)
SD
vs O-SD
(p value)
PD
vs O-SD
(p value)
Number of alleles 69 34 52
Class distribution of families
NA 7 (4%) 5 (11%) 2 (3%) ns ns ns
noFH 25 (15%) 6 (14%) 5 (7%) ns ns ns
FH 24 (14%) 15 (34%) 6 (9%) 0.004 ns 0.001
LFL 45 (26%) 13 (30%) 24 (34%) ns ns ns
LFS 70 (41%) 5 (11%) 33 (47%) 0.0002 ns 0.0001
Total 171 (100%) 44 (100%) 70 (100%)
Families with
individuals with
multiple tumors
107 (63%) 17 (39%) 40 (57%) 0.006 ns ns